{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:44:59Z","timestamp":1791135899275,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1160,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:p>HLA\u2010mismatched bone marrow transplantation (BMT) is hampered by three major complications: graft rejection, acute graft\u2010versus\u2010host disease (aGVHD) and delayed immune reconstitution. Infusion of anti\u2010LFA1 plus anti\u2010CD2 monoclonal antibodies (MAb), combined with <jats:italic>ex\u2010vivo<\/jats:italic> T\u2010cell depletion of the graft, was efficient in preventing graft rejection and aGVHD. Nevertheless, disease\u2010free survival was limited by the high frequency of lethal infections, including EBV\u2010induced lymphoproliferative disease (BLPD), which originates mostly from donor B cells, with an incidence of 5\u201330%. To decrease the rate of this complication, <jats:italic>ex\u2010vivo<\/jats:italic> B\u2010cell depletion was attempted.<\/jats:p><jats:p>This study compares a group of 19 patients who received a T\u2010 and B\u2010cell\u2010depleted marrow from an HLA\u2010mismatched related donor with a retrospective control group of 19 patients, who had received T\u2010cell\u2010depleted marrow by the same method. The level of T\u2010cell depletion was similar in the two groups. For B\u2010cell depletion, two different methods were compared. The median number of B cells infused in the study group was 0.46\/kg. Engraftment and aGVHD incidence were similar in the two groups. No EBV donor\u2010derived BPLD occurred in the study group, compared with seven in the control group, four of whom died because of EBV\u2010BPLD. Event\u2010free survival was significantly different between the two groups. We conclude that <jats:italic>ex\u2010vivo<\/jats:italic> B\u2010cell depletion of the graft may be a useful means of preventing EBV\u2010BPLD, and warrants further study on a larger group of patients.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00972.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:05:51Z","timestamp":1047362751000},"page":"543-551","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Prevention of EBV\u2010induced B\u2010lymphoproliferative disorder by <i>ex vivo<\/i> marrow B\u2010cell depletion in HLA\u2010phenoidentical or non\u2010identical T\u2010depleted bone marrow transplantation"],"prefix":"10.1111","volume":"103","author":[{"family":"Cavazzana\u2010Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bensoussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jabado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yvon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Moskwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Tachet Des Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Virion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"LE Deist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002223220801"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T\u2010cell\u2010depleted haploidentical \u2018three\u2010loci\u2019 incompatible transplants in leukemia patients by adding of recombinant human granulocyte colony\u2010stimulating factor\u2010mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa F.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198509263131301"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00010"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30252-1"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-2-199"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1997.tb00976.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198609000-00001"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.4831024.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V62.2.291.291"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242102"},{"key":"e_1_2_6_13_2","first-page":"5","article-title":"Cultivation, characterization and identification of human tumor cells with emphasis on kidney, testis and bladder tumors","volume":"49","author":"Fogh J.","year":"1978","journal-title":"National Cancer Institute Monograph"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood.V83.9.2392.2392","article-title":"Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?","volume":"83","author":"Forman S.J.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.2.287"},{"key":"e_1_2_6_17_2","first-page":"597","article-title":"Control of graft versus host disease and graft rejection by T\u2010cell depletion of donor and recipient with CAMPATH\u20101 antibodies: results of matched sibling transplants for malignant diseases","volume":"13","author":"Hale F.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_18_2","first-page":"305","article-title":"Recent results using CAMPATH\u2010I antibodies to control GVHD and graft rejection","volume":"17","author":"Hale G.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198009043031007"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood.V75.4.1017.1017","article-title":"Treatment of corticosteroid resistant acute graft\u2010versus\u2010host disease by in vivo administration of anti\u2010interleukin\u20102 receptor monoclonal antibody (B\u2010B10)","volume":"75","author":"Herv\u00e9 P.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.3-381"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1542\/peds.98.3.420","article-title":"Bone marrow transplantation from genetically HLA\u2010nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection","volume":"98","author":"Jabado N.","year":"1996","journal-title":"Pediatrics"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.5.1340.1340"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303043280901"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T\u2010cell depleted bone marrow transplants correlate with development of graft versus\u2010host disease","volume":"68","author":"Kernan N.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82003-7"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199701000-00006"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/14.19.7569"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301703"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4383.4383"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08904.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1182\/blood.V87.9.3984.bloodjournal8793984","article-title":"Analysis of T\u2010cell repopulation after allogenic bone marrow transplantation: significant differences between recipients of T\u2010cell depleted and unmanipulated grafts","volume":"87","author":"Roux E.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104113241501"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805193182013"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","article-title":"Epstein Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation","volume":"71","author":"Shapiro R.S.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.4.1248.1248"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08150.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood.V86.9.3590.bloodjournal8693590","article-title":"Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T\u2010cell depletion: major prognostic impact of HLA class I identity between donor and recipient","volume":"86","author":"Spencer A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_39_2","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis","volume":"126","author":"Taswell C.","year":"1981","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.9.517"},{"key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood.V88.9.3615.bloodjournal8893615","article-title":"Lymphotropic herpesviruses in allogenic bone marrow transplantation","volume":"88","author":"Wang F.Z.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3532324"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.520.520"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00972.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00972.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00972.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T05:25:52Z","timestamp":1698470752000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00972.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00972.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00972.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}